Recent developments in targeted therapies for chronic lymphocytic leukemia
3 Views
administrator
07/08/23
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jacqueline Barrientos, MD, of the North Shore-LIJ Cancer Institute, Lake Success, NY, provides a summary of recent developments in new therapeutic options for patients with chronic lymphocytic leukemia (CLL), including those with known complications, such as the presence of 17p deletion.
-
Category
Show more
Facebook Comments
No comments found